NEW YORK (GenomeWeb) – DeNovo Sciences today announced a collaborative research agreement with South Texas Accelerated Research Therapeutics (START) to perform whole-genome sequencing on circulating tumor cells.

Under the terms of the agreement, START will collect blood from cancer patients and use DeNovo instruments and reagents for CTC enrichment and purification. The enriched CTCs will then be sent to a lab for whole-genome sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.